Cargando…

Identification of Leucinostatins from Ophiocordyceps sp. as Antiparasitic Agents against Trypanosoma cruzi

[Image: see text] Safe and effective treatments for Chagas disease, a potentially fatal parasitic infection associated with cardiac and gastrointestinal pathology and caused by the kinetoplastid parasite Trypanosoma cruzi, have yet to be developed. Benznidazole and nifurtimox, which are currently th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernatchez, Jean A., Kil, Yun-Seo, Barbosa da Silva, Elany, Thomas, Diane, McCall, Laura-Isobel, Wendt, Karen L., Souza, Julia M., Ackermann, Jasmin, McKerrow, James H., Cichewicz, Robert H., Siqueira-Neto, Jair L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908367/ https://www.ncbi.nlm.nih.gov/pubmed/35284725 http://dx.doi.org/10.1021/acsomega.1c06347

Ejemplares similares

High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
por: Bernatchez, Jean A., et al.
Publicado: (2020)

Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2015)

Location, Location, Location: Five Facts about Tissue Tropism and Pathogenesis
por: McCall, Laura-Isobel, et al.
Publicado: (2016)

Persistent biofluid small molecule alterations induced by Trypanosoma cruzi infection are not restored by antiparasitic treatment
por: Dean, Danya A., et al.
Publicado: (2023)

Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole
por: Calvet, Claudia Magalhães, et al.
Publicado: (2020)

Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
por: Engel, Juan C., et al.
Publicado: (1998)

The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
por: Doyle, Patricia S., et al.
Publicado: (2011)

Spatial metabolomics identifies localized chemical changes in heart tissue during chronic cardiac Chagas Disease
por: Dean, Danya A., et al.
Publicado: (2021)

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010)

Antiparasitic Effect of Stilbene and Terphenyl Compounds against Trypanosoma cruzi Parasites
por: Bruno, Federica, et al.
Publicado: (2021)

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
por: Vieira, Debora F., et al.
Publicado: (2014)

Dysregulation of Glycerophosphocholines in the Cutaneous Lesion Caused by Leishmania major in Experimental Murine Models
por: Parab, Adwaita R., et al.
Publicado: (2021)

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
por: Chen, Yen Ting, et al.
Publicado: (2010)

Hybrids of Cinchona Alkaloids and Bile Acids as Antiparasitic Agents Against Trypanosoma cruzi
por: Musikant, Daniel, et al.
Publicado: (2019)

Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi
por: de Freitas Oliveira, Johny Wysllas, et al.
Publicado: (2021)

In Vitro Validation of Antiparasitic Activity of PLA-Nanoparticles of Sodium Diethyldithiocarbamate against Trypanosoma cruzi
por: de Freitas Oliveira, Johny Wysllas, et al.
Publicado: (2022)

Antiparasitic Activity of Plumbago auriculata Extracts and Its Naphthoquinone Plumbagin against Trypanosoma cruzi
por: Peres, Raiza Brandão, et al.
Publicado: (2023)

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
por: Calvet, Claudia M., et al.
Publicado: (2014)

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
por: Chen, Chiung-Kuang, et al.
Publicado: (2009)

Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
por: Gunatilleke, Shamila S., et al.
Publicado: (2012)

Antiparasitic Activity of Hippeastrum Species and Synergistic Interaction between Montanine and Benznidazole against Trypanosoma cruzi
por: Piñeiro, Mauricio, et al.
Publicado: (2023)

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
por: Cascabulho, Cynthia M, et al.
Publicado: (2020)

Building Natural Product Libraries Using Quantitative Clade-Based and Chemical Clustering Strategies
por: Anderson, Victoria M., et al.
Publicado: (2021)

Correction for Anderson et al., “Building Natural Product Libraries Using Quantitative Clade-Based and Chemical Clustering Strategies”
por: Anderson, Victoria M., et al.
Publicado: (2021)

Insights gained into respiratory infection pathogenesis using lung tissue metabolomics
por: Bernatchez, Jean A., et al.
Publicado: (2020)

Cysteine proteases in protozoan parasites
por: Siqueira-Neto, Jair L., et al.
Publicado: (2018)

Antiprotozoal Structure–Activity Relationships of Synthetic Leucinostatin Derivatives and Elucidation of their Mode of Action
por: Brand, Michael, et al.
Publicado: (2021)

Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes
por: Albareda, María C., et al.
Publicado: (2018)

4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection
por: Calvet, Claudia Magalhaes, et al.
Publicado: (2017)

Mining a Cathepsin Inhibitor Library for New Antiparasitic Drug Leads
por: Ang, Kenny K. H., et al.
Publicado: (2011)

Targeting Ergosterol Biosynthesis in Leishmania donovani: Essentiality of Sterol 14alpha-demethylase
por: McCall, Laura-Isobel, et al.
Publicado: (2015)

TcSNP: a database of genetic variation in Trypanosoma cruzi
por: Ackermann, Alejandro A., et al.
Publicado: (2009)

Genome-scale metabolic models highlight stage-specific differences in essential metabolic pathways in Trypanosoma cruzi
por: Shiratsubaki, Isabel S., et al.
Publicado: (2020)

Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
por: Morais, Thiago R., et al.
Publicado: (2020)

A systematic review of the diagnostic aspects and use of Trypanosoma rangeli as an immunogen for Trypanosoma cruzi infection
por: Bayão, Taciana de Souza, et al.
Publicado: (2020)

Biosynthesis of Antibiotic Leucinostatins in Bio-control Fungus Purpureocillium lilacinum and Their Inhibition on Phytophthora Revealed by Genome Mining
por: Wang, Gang, et al.
Publicado: (2016)

Profiling the Trypanosoma cruzi Phosphoproteome
por: Marchini, Fabricio K., et al.
Publicado: (2011)

Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014)

Endothelial Transmigration by Trypanosoma cruzi
por: Coates, Bria M., et al.
Publicado: (2013)

The N-myristoylome of Trypanosoma cruzi
por: Roberts, Adam J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hmg8t2gjemb5su4rppqd2hf4fg